SECsense Logo

180 Life Sciences Corp. 8-K/A Report: Key Amendments & Compliance Insights

$ATNF
Form 8-K/A
Filed on: 2025-01-02
Source
180 Life Sciences Corp. 8-K/A Report: Key Amendments & Compliance Insights

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Identification:
  • Company Name: 180 Life Sciences Corp.
  • CIK (Central Index Key): 0001690080
  • SEC Reporting Category: Form 8-K/A (Amendment No. 1)
  1. Reporting Date:
  • The information pertains to the date of December 27, 2024.
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share
    • Ticker Symbol: ATNF (listed on NASDAQ)
  • Warrants to Purchase Shares:
    • Ticker Symbol: ATNFW (listed on NASDAQ)
  1. Purpose of Filing:
  • This is an amendment to a previously filed Form 8-K (originally filed on December 31, 2024) to include omitted items:
    • Item 3.03 (which typically relates to the material modification of rights of security holders)
    • Item 5.01 (which generally pertains to changes in control of the registrant)
  1. Contact Information:
  • Address: 3000 El Camino Real, Building 4, Suite 200, Palo Alto, CA 94306
  • Phone: 650-507-0669
  1. Regulatory Compliance:
  • The filing is compliant with SEC regulations and aims to correct previous omissions without altering the overall disclosures made in the original report.

This amendment serves to ensure accurate and complete reporting to investors and regulatory bodies, reflecting the company's ongoing compliance and transparency regarding its securities.